written on 06.06.2014
Tags:
,

Ranbaxy decision shows why FDA reluctant to rely on European inspections

TAGS: ,

Europe has been pushing the U.S. in trade negotiations to accept their inspections of European drugmakers in lieu of doing their own, and vice versa, but the approach the FDA and European regulators have taken to problems at a Ranbaxy Laboratories plant illustrate why this has become a contentious issue.

Latest Report